This study examined the responsiveness of dopaminergic neurons to PRL and the expression of PRL receptors in fetal hypothalamic cells. Hypothalamic cells were cultured in medium containing 5 or 25 mM potassium (K ϩ ) with or without 5% FBS. Rat PRL (rPRL) treatment (10 -1000 ng/ml) for 10 days increased tyrosine hydroxylase (TH) activity 1.6-to 1.8-fold in dopaminergic neurons cultured in serum-containing medium with 25 mM K ϩ , but not in defined medium or any medium with 5 mM K ϩ . The rPRL-induced increase in TH activity was observed at 10 -1000 ng/ml after both 1 and 10 days of rPRL treatment, whereas 1 ng/ml was not effective. TH activity was not altered after 1-12 h of rPRL treatment (100 ng/ml), but was increased 1.4-fold after 1-3 days and 1.8-fold after 5-10 days. The colocalization of PRL receptors and TH was evaluated by double labeled immunocytochemistry. PRL receptor immunostaining was observed in most TH-immunoreactive cells cultured in either defined or serum-containing medium with or without 10 days of rPRL treatment (100 ng/ml). As assessed by reverse transcriptase-PCR, the long form, but not the short form, of the PRL receptor was expressed in the hypothalamic cells regardless of medium composition, similar to the expression pattern in adult mediobasal hypothalamus from ovariectomized rats. These data indicate that a factor present in FBS imparts PRL responsiveness to hypothalamic dopaminergic neurons in vitro. 1-4) . The TIDA neurons have their perikarya in the arcuate nucleus of the hypothalamus and the nerve terminals in the median eminence (5). PRL feeds back to regulate its own secretion, in part by increasing dopamine secretion and synthesis, including altering tyrosine hydroxylase (TH) activity (1, 2). Although the cellular mechanism(s) by which this occurs is still not completely understood, augmented TH gene expression may contribute to the hyperprolactinemia-induced increase in TH activity (6, 7). Moreover, phosphorylation/dephosphorylation probably plays a role in the alteration in TH activity caused by acute changes in PRL (8, 9) . This short loop feedback arrangement is operational in vivo during many, but not all, endocrine conditions and is essential to maintain low basal circulating PRL levels and thus prevent deleterious effects of chronic hyperprolactinemia (10). An exception is lactation, an endocrine state when hyperprolactinemia is desirable for normal function (11). Possibly as a physiological adaptation, the TIDA neurons become unresponsive to high levels of PRL in the cerebral ventricles during midlactation in the rat (12, 13).
observed in most TH-immunoreactive cells cultured in either defined or serum-containing medium with or without 10 days of rPRL treatment (100 ng/ml). As assessed by reverse transcriptase-PCR, the long form, but not the short form, of the PRL receptor was expressed in the hypothalamic cells regardless of medium composition, similar to the expression pattern in adult mediobasal hypothalamus from ovariectomized rats. These data indicate that a factor present in FBS imparts PRL responsiveness to hypothalamic dopaminergic neurons in vitro. The effective PRL concentrations and the time course for PRL's action in vitro are within the physiological range in vivo. The colocalization of PRL receptor in dopaminergic neurons provides anatomical evidence for a direct effect of PRL, with the long form of the PRL receptor being the predominant form in the hypothalamic cells. (Endocrinology 138: 3016 -3023, 1997) D OPAMINE FROM the tuberoinfundibular dopaminergic (TIDA) neurons in the hypothalamus is the major PRL-inhibiting hormone, providing for the tonic suppression of PRL secretion from the anterior pituitary (1) (2) (3) (4) . The TIDA neurons have their perikarya in the arcuate nucleus of the hypothalamus and the nerve terminals in the median eminence (5) . PRL feeds back to regulate its own secretion, in part by increasing dopamine secretion and synthesis, including altering tyrosine hydroxylase (TH) activity (1, 2) . Although the cellular mechanism(s) by which this occurs is still not completely understood, augmented TH gene expression may contribute to the hyperprolactinemia-induced increase in TH activity (6, 7) . Moreover, phosphorylation/dephosphorylation probably plays a role in the alteration in TH activity caused by acute changes in PRL (8, 9) . This short loop feedback arrangement is operational in vivo during many, but not all, endocrine conditions and is essential to maintain low basal circulating PRL levels and thus prevent deleterious effects of chronic hyperprolactinemia (10) . An exception is lactation, an endocrine state when hyperprolactinemia is desirable for normal function (11) . Possibly as a physiological adaptation, the TIDA neurons become unresponsive to high levels of PRL in the cerebral ventricles during midlactation in the rat (12, 13) .
There is increasing evidence that PRL receptors are localized in the hypothalamus, although the neuronal cell types that contain these receptors have not been elucidated. PRLbinding sites are found in hypothalamic tissue (14) and are detected in the arcuate nucleus and/or median eminence by autoradiographic methods (15) (16) (17) . PRL receptor messenger RNA (mRNA) is detected in the hypothalamus by in situ hybridization techniques (18 -20) , with a pattern of expression in the arcuate nucleus anatomically similar to that in the TIDA neurons (20) . To date, two isoforms of the PRL receptor, long and short, have been identified in normal rat tissues (21) . Both long and short forms of the PRL receptor are expressed in hypothalamic tissue, as determined by reverse transcriptase-PCR (RT-PCR) (22, 23) , although the long form of the receptor is the predominant form (23) . A major goal of this study was to determine the existence of PRL receptors on dopaminergic neurons.
Although dopaminergic neurons are present in hypothalamic cell cultures, TH activity was not stimulated by PRL administration when the cells were cultured in a serum-free, chemically defined medium (24, 25) . In contrast, hypothalamic dopaminergic neurons were activated by PRL under culture conditions that included horse serum and/or FBS (26, 27) . The stimulatory effect of PRL was specific to dopaminergic neurons from hypothalamic, but not mesencephalic, tissue (27) . However, it is not clear whether the presence of serum or different experimental conditions between laboratories contributed to differences in the responsiveness to PRL.
Mechanistic studies to understand PRL's action on dopaminergic neurons are dependent on establishing an adequate in vitro model. The objectives for this study were 1) to assess the effects of medium composition on the ability of PRL to increase TH activity in vitro, 2) to establish time and concentration dependency for PRL's action on TH activity, 3) to determine whether PRL receptors are colocalized with TH in hypothalamic dopaminergic neurons, and 4) to examine the PRL receptor isoform(s) expressed in the hypothalamic cell cultures.
Materials and Methods Animals
Adult female (200 -250 g) and male (300 -350 g) Sprague-Dawley rats were obtained from Sasco (Omaha, NE) or Harlan (Indianapolis, IN). Rats were housed under controlled temperature and lighting conditions and supplied with food and water ad libitum. All procedures were approved by the University of Kansas Medical Center or Southern Illinois University animal care and use committee. The estrous cycles of female rats were followed by daily vaginal lavage. Each female was placed with a single male on the day of proestrus for mating purposes. If sperm were present on the following day, it was designated day 0 of pregnancy. Pregnant rats were used for cell culture experiments on day 19 or 20 of pregnancy. Some female rats were ovariectomized, and the mediobasal hypothalamus (MBH) and a fragment of liver were dissected for RNA extraction after 14 days. The MBH was dissected to include primarily the arcuate nucleus and median eminence.
Fetal hypothalamic cell cultures
Fetal hypothalamic cells were cultured as described previously (25) , using a modification of the method described by Ahmed et al. (28) . Briefly, 3-5 five pregnant rats were anesthetized with ether, and the fetuses were removed through a midline abdominal incision under aseptic conditions. The medioventral hypothalamus was excised to an approximate depth of 1 mm with fine dissecting scissors using horizontal cuts posterior to the optic chiasm and anterior to the mamillary bodies and vertical cuts halfway between the median eminence and hypothalamic sulcus. The tissue was immediately placed in sterile dispersion buffer without phenol red at 4 -10 C. As described previously (25) , the hypothalamic cells were dispersed and resuspended in a modified high glucose Dulbecco's medium containing 2.5% heat-inactivated FBS and 5% heat-inactivated horse serum. The medium for all experiments was phenol red free. For some cultures, the medium contained 5.4 mm potassium (K ϩ ) provided with the commercial medium, whereas for other cultures, additional potassium chloride was added for a final concentration of 25 mm K ϩ . The cells were plated on surfaces that had previously been coated with poly-d-lysine (100 g/ml). For determination of TH activity, the cells were plated at a density of 150,000 cells/0.2 ml⅐well in 96-well plates. For RNA extraction, the cells were plated at a density of 1 ϫ 10 6 cells/1 ml⅐well in 24-well plates. For immunocytochemistry, the cells were cultured at a density of 400,000 cells/0.4 ml⅐well in 8-well Lab-Tek Permanox chamber slides (Life Science Products, Denver, CO). Eighteen to 24 h after plating the cells, the medium was replaced with serum-free, modified, high glucose Dulbecco's medium supplemented with ITS ϩ (1:100; Collaborative Biomedical Products, Bedford, MA), 3.5 m linolenic acid, and 10 m putrescine. For serum-containing medium, 5% heat-inactivated FBS was also added. The K ϩ concentration was adjusted as indicated for individual experiments. The medium was changed daily, and rat PRL (rPRL; B-7, National Hormone and Pituitary Program) was included so that the indicated treatment would be completed on day 10 in vitro.
TH activity
TH activity was determined on day 10 of culture. The hypothalamic cells were preincubated for 15 min in phenol red-free Earles' Balanced Salt Solution (Life Technologies, Grand Island, NY) to which 20 m tyrosine, 20 mm potassium chloride, and rPRL, when indicated, were added. The preincubation medium was removed, and 100 l medium containing 100 m brocresine (4-bromo-hydroxybenzyloxyamine; gift from American Cyanamid Co., Pearl River, NY), an aromatic amino acid decarboxylase inhibitor, was added. The cells were then incubated for 60 min under a humidified atmosphere of 90% air-10% carbon dioxide, with rPRL included as indicated. At the end of the incubation period, the medium was removed, acidified with 10 l 1 n perchloric acid, and frozen until samples were analyzed for medium l-dihydroxyphenylalanine (DOPA) accumulation by HPLC with electrochemical detection as described previously (6, 25) .
Double labeled immunocytochemistry
On day 10 of culture, hypothalamic cells were fixed for 15 min in 4% paraformaldehyde in PBS and washed twice in PBS for 5 min. Nonspecific binding was blocked with 10% normal horse serum and 10% normal donkey serum in PBS for 1 h. After rinsing three times with PBS, the cells were incubated successively with avidin block and biotin block (Vector Laboratories, Burlingame, CA) for 15 min and then rinsed with PBS. The cells were incubated for 24 h at 4 C with mouse monoclonal antibodies against the rPRL receptor (U-6; 5 g/ml; gift from Dr. Paul Kelly, INSERM, Paris, France) and/or a rabbit polyclonal antiserum against rat TH (1:1250, East Acres Biologicals, Southbridge, MA) diluted with 2% normal horse serum, 2% normal donkey serum, and 0.3% Triton X-100 in PBS. The PRL receptor antibody recognizes an epitope on the extracellular dopamine distinct from the binding domain (29) and, therefore, would recognize both the occupied and unoccupied receptors of the long and short forms of the PRL receptor. Control wells were incubated in the absence of antiserum or with mouse IgG1. In separate experiments, the fixed cells were incubated with PRL receptor antibodies (U-6; 5 g/ml) and either rabbit antineuron-specific enolase (NSE; Incstar, Stillwater, MN) or rabbit antiglial fibrillary acidic protein (GFAP; Incstar) at a concentration supplied by the manufacturer. After rinsing six times with PBS at room temperature, the cells were incubated for 1 h with a serum block as described above, then for 1 h at room temperature with biotinylated horse antimouse IgG (1:200; Vector Laboratories) and fluorescein (dichlorotriazinylamino fluorescein)-conjugated donkey antirabbit IgG (1:80; Jackson ImmunoResearch Laboratories, West Grove, PA). After rinsing six times with PBS, the cells were incubated for 1 h at room temperature with lissamine rhodamine (lissamine rhodamine B sulfonyl chloride)-conjugated strepavidin (22.5 g/ml). After rinsing six times with PBS, coverslips were mounted with Fluoromount G. The immunostaining was visualized with a Nikon Optiphot microscope (Nikon Corp., Melville, NY) using a mercury lamp with a blue (492 nm) or green (570 nm) excitor filter block for fluorescein or rhodamine, respectively.
PRL receptor RT-PCR
RNA was isolated by the method of Chomczynski and Sacchi (30) as modified for the RNAzol B method (Tel-Test, Friendswood, TX). Hypothalamic cells (2 ϫ 10 6 cells) were lysed by adding 0.8 ml RNAzol B reagent. RNA was extracted according to manufacturer's instructions and stored at Ϫ70 C. Complementary DNA (cDNA) was synthesized from RNA by the SuperScript Preamplification System for First Strand cDNA Synthesis (Life Technologies). Oligonucleotide primers for the long and short forms of the PRL receptor were synthesized by the Biotech Center at the University of Kansas Medical Center and were identical to those used by Shirota et al. (31) . The primers for the short form of the receptor recognized nucleotides at positions 624 -653 and 924 -953. The first primer for the long form of the receptor was the same as the first primer for the short form, whereas the second primer recognized nucleotides at position 1014 -1043 of the long form of the receptor. These primers generate PCR products of 330 and 420 bp for the short and long forms of the PRL receptor, respectively. These same primers have been used for detection of PRL receptor mRNA in the rat hypothalamus and pituitary (22, 23) . cDNAs were amplified through 30 cycles using Taq polymerase (22) . After amplification, the samples were electrophoresed on 1.5% agarose gels, and the PCR product was visualized with ethidium bromide staining and compared to a known standard for size determination. As negative controls, reactions were performed with RNA that had not been reverse transcribed and with samples lacking RNA in the RT reaction. Aliquots of the PCR products were incubated for 1 h at 60 C with BsaBI to evaluate digestion by an appropriate restriction endonuclease.
Statistical analysis
To normalize data, experimental values were adjusted to a percentage of the control value for individual experiments. The control value was the mean of 12 wells, and each experimental value was the mean of triplicate wells for each hypothalamic culture. The results are expressed as the mean Ϯ se of determinations from four to nine different experiments. The percentage of immunoreactive cells was quantified by counting the total number of cells and the number of fluorescein-or rhodamine-labeled cells in 20 randomly selected microscope fields under ϫ400 magnification. The percentage of labeled cells for each experiment was determined, and a final mean was calculated form all eight experiments. Data were evaluated by ANOVA, and multiple comparisons were made with Fisher's least significant procedures (32, 33).
Results

Effect of PRL on TH activity in fetal hypothalamic cells
The first experiment evaluated the effect of medium composition on TH activity and responsiveness to PRL in fetal hypothalamic cell cultures. Given that TH in the stalk-median eminence may exist in a relatively activated state most of the time (34), some wells were maintained in medium containing 25 mm K ϩ . Control TH activity was 124 Ϯ 23 or 114 Ϯ 23 pg/150,000 cells⅐h with 5 mm K ϩ and 482 Ϯ 74 or 370 Ϯ 67 with 25 mm K ϩ in defined or serum-containing medium, respectively. rPRL (10 -1000 ng/ml) was included for the entire 10 days in vitro. rPRL at concentrations of 10 -1000 ng/ml increased (P Ͻ 0.05) TH activity in serumcontaining, but not defined, medium with 25 mm K ϩ (Fig. 1) . rPRL did not alter TH activity in cells cultured with 5 mm K ϩ in either defined or serum-containing medium (Fig. 1) . All subsequent experiments were performed with medium containing 25 mm K ϩ and 5% FBS. The ability of rat PRL (1-1000 ng/ml) to stimulate TH activity was examined after 1 or 10 days of treatment. Rat PRL treatment (10 -1000 ng/ml) caused a significant (P Ͻ 0.05) increase in TH activity at both 1 and 10 days, although the increase at 10 days was slightly greater than that at 1 day (Fig. 2) . The lowest PRL concentration (1 ng/ml) did not cause a significant increase in TH activity (Fig. 2) . The time course for PRL's action on dopaminergic neurons was evaluated from 0 -10 days. TH activity was 126% (P ϭ 0.06) of control levels after 12 h of rPRL treatment (Fig. 3) . TH activity was significantly increased (P Ͻ 0.05) after 1 day of rPRL exposure and remained elevated for 3 days. An additional increase in enzyme activity was observed between 3 and 5 days of rPRL treatment, and TH activity remained elevated after continuous exposure for 7 and 10 days.
Colocalization of PRL receptor and TH immunoreactivity
Double label immunocytochemistry was used to determine whether PRL receptors are localized in dopaminergic neurons. Figure 4 shows a number of TH-immunoreactive cells (fluorescein label) that are also immunoreactive for PRL receptors (rhodamine label) in both defined (Fig. 4, A and B ) and serum-containing (Fig. 4, C and D) media. The percentage of total cells that were immunopositive for TH was 6.7 Ϯ 0.6% (n ϭ 8) or 6.8 Ϯ 0.4% in defined or serum-containing medium, respectively. Greater than 95% of TH-containing cells were also immunopositive for PRL receptors. However, a few TH-immunopositive cells did not show PRL receptor immunostaining (Fig. 4A) . PRL receptor immunostaining was also observed in non-TH-containing cells. Indeed, 18.9 Ϯ 2.3% or 24.2 Ϯ 2.3% of the cells in defined or serum-containing medium were immunopositive for PRL receptor. The TH-immunoreactive and PRL receptor-immunoreactive cells were only subpopulations, as the majority of cells were not labeled for either antigen. Similar results were observed in wells treated with PRL (100 ng/ml) for 10 days (data not   FIG. 1 . Effect of medium composition on the response of dopaminergic neurons to PRL in vitro. Fetal hypothalamic cells were cultured in a serum-free, chemically defined medium or in medium containing 5% FBS with either 5 or 25 mM K ϩ . Experimental wells were incubated without (control) or with rat PRL (10 -1000 ng/ml) for 10 days, and the medium was changed daily. TH activity was determined by the accumulation of DOPA during the final 1 h of the incubation period. Experimental values were individually normalized to percent of their respective control. Asterisks indicate values significantly different (P Ͻ 0.05) from the control. Each value is the mean Ϯ SE of determinations from four experiments.
FIG. 2. The concentration dependence of PRL's action on TH activity
in fetal hypothalamic cells. Cells were cultured in serum-containing medium without (control) or with different concentrations of rPRL (1-1000 ng/ml) for 1 or 10 days, and DOPA accumulation was determined during the final 1 h. Asterisks indicate values significantly different (P Ͻ 0.05) from the control. Each value is the mean Ϯ SE of determinations of three (1 ng/ml) or seven to nine (10 -1000 ng/ml) experiments.
shown). Both fluorescein and rhodamine staining were absent when the primary antisera were omitted (Fig. 4 , E and F, respectively) or when mouse IgG1 was included as a control (data not shown).
As PRL receptor immunostaining was observed in nondopaminergic cells, the localization of PRL receptors in neuronal or glial cells was evaluated. All of the PRL receptor immunostaining was localized in a subpopulation of NSEimmunoreactive cells in both defined (Fig. 5, A and B) and serum-containing medium (data not shown). In contrast, there were no PRL receptors found in GFAP-immunolabeled cells in either defined (Fig. 5, C and D) or serum-containing medium (data not shown). There was no detectable staining in control wells when the primary antiserum was omitted.
Expression of the long form of the PRL receptor in fetal hypothalamic cells
RT-PCR was used to determine whether PRL mRNA was present in the hypothalamic cell cultures and to ascertain which form of the receptor was expressed. As evidence by the 420-bp PCR product, the mRNA for the long form of the PRL receptor was expressed in the fetal hypothalamic cell cultures in both defined and serum-containing media with or without rPRL treatment (Fig. 6, left panel) . Similarly, expression of the long form of the PRL receptor was also evident in MBH tissue from adult ovariectomized rats. The mRNA for the short form of the PRL receptor was not detectable or was only faintly detectable in fetal hypothalamic cells with any treatment paradigm or in adult MBH (Fig. 6, right panel) . As a positive control, both the long and short forms of the PRL receptor were expressed in liver tissue from adult ovariectomized rats (Fig. 6) . No PCR product was detected when RT was omitted (Fig. 6 ) or when RNA was absent from the RT reaction (data not shown). After digestion with BsaBI, the 420-bp PCR product for the long form was cut into the predicted 204-and 216-bp DNA fragments and the 330-bp PCR product for the short form was cut into the predicted 204-and 126-bp DNA fragments.
Discussion
One of the central tenets of the regulation of PRL secretion is that PRL increases the activity of TIDA neurons by a short loop feedback mechanism. Although PRL's ability to increase the synthesis and secretion of dopamine is well established (1-3), it is still not known whether PRL acts directly on dopaminergic neurons. We report here that dopaminergic neurons in fetal hypothalamic cells contain PRL receptors and that the primary isoform expressed is the long form of the PRL receptor. However, PRL stimulated dopamine synthesis under some, but not all, culture conditions, even though PRL receptors were expressed under all conditions examined. This indicates that the presence of PRL receptors is not sufficient for PRL's action on TH. Indeed, a serum factor appears to be important for the PRL-induced increase in TH activity in fetal hypothalamic cell cultures.
The colocalization of PRL receptors and TH provides the first anatomical evidence for a direct effect of PRL on dopaminergic neurons. Indeed, immunostaining for the extracellular domain of the PRL receptor was observed in almost all of the TH immunoreactive neurons. However, as other, as yet unidentified, neuronal cells in the hypothalamic cultures were also immunopositive for PRL receptor, an indirect effect cannot be completely ruled out. Indeed, some neuropeptides alter TIDA neuronal activity in vivo (35, 36), and the neuronal activity of at least some of these is altered by PRL (7, 37). The cultured cells in this study were from the medioventral hypothalamus, which in the adult rat contains TIDA neurons (38). Thus, it is likely that dopaminergic cells in the fetal hypothalamic cell cultures correspond to TIDA neurons. Indeed, Beyer et al. (27) observed a PRL-induced increase in TH activity in cultured cells from the hypothalamus, but not in those from the midbrain. It is not clear whether the PRL receptor and TH colocalization observed in the fetal cultures is applicable to the adult rat. However, it is notable that PRL binding, PRL receptor immunostaining, and PRL receptor mRNA have been identified in the arcuatemedian eminence region of the hypothalamus (15) (16) (17) (18) (19) (20) . Although the expression of PRL receptor is widespread in the rat fetus and increases late in gestation (39), it is not known whether PRL receptor expression in the culture cells reflects the cell source or if expression is induced during the 10 days in vitro.
In addition to PRL receptor protein identified by immunocytochemistry, PRL receptor mRNA was identified in the hypothalamic cell cultures by RT-PCR. There are at least two PRL receptor isoforms, short and long, expressed in rat tissues (21) . Although both forms of the PRL receptor are functional, there is differential regulation of expression of the two forms, but no functional variation is yet known. In the present study, only the long form was detected by RT-PCR in fetal hypothalamic cells and in adult MBH tissue of ovariectomized rats. No PCR product for the short form was detected in six different hypothalamic cultures or six different MBH samples, even though a strong signal for the short form was seen in liver tissues. These data indicate that, similar to the adult hypothalamus, the long form is the predominant form in the hypothalamic cell cultures, indicating that the cell cultures may be appropriate to examine the mech- anism for PRL's action on dopaminergic neurons. Both the long and short forms of the receptor have been identified by RT-PCR in the hypothalamus of estrogen-treated ovariectomized rats (22) and in cycling female rats (23) using the same primer pairs. However, 99% of PRL receptor mRNA in the hypothalamus encodes for the long form of the receptor in diestrous and proestrous rats (23) . The inability to detect the short form of the PRL receptor in the present study may be due to the relative sensitivity of ethidium bromide staining or to the lack of estrogen or ovarian input. Indeed, ovariectomy decreases PRL binding in the hypothalamus, whereas estrogen reverses this decrease (14) .
The concentration dependence and time response for PRL's action on TH activity in the hypothalamic cell cultures and with a rabbit anti-rat TH (A-D). The primary antiserum was absent from control wells (E and F). Subsequently, all wells were incubated with donkey fluorescein-conjugated antirabbit IgG and horse biotinylated antimouse IgG. This was followed by incubation with rhodamineconjugated streptavidin. Note that most of the green fluorescein-labeled TH-containing cells (A and C) are also rhodamine labeled for PRL receptors (B and D) in both defined (A and B) and serum-containing (C and D) media. The arrows show representative double labeled cells. The majority of TH-containing cells were also immunopositive for PRL receptor, but PRL receptor was not detectable (or was only faintly detectable) in a few TH-immunopositive cells, as shown by the arrowhead (A and B) . PRL receptor immunostaining was also observed in non-TH cells. The TH-and PRL receptor-immunoreactive cells were only subpopulations, as the majority of cells were not labeled for either antigen. Note the absence of both fluorescein and rhodamine staining in control wells (E and F). Similar results were observed in eight separate experiments.
was very similar to the in vivo effect of PRL on TIDA neuronal activity. The effective concentrations of PRL were 10 -1000 ng/ml, which would correspond to basal circulating levels (10 ng/ml) and the range of circulating PRL levels (100 -1000 ng/ml) during the PRL surges associated with reproduction. The PRL concentration (1 ng/ml), similar to bromocriptinesuppressed circulating PRL levels, did not significantly alter TH activity. A significant increase in TH activity was observed between 12 and 24 h of PRL exposure. This is very similar to the time course required for in vivo PRL treatment to increase TIDA neuronal activity (2). Indeed, Johnston et al. (40) reported that protein synthesis was required early during the delay period for PRL's action, as cycloheximide administered during the first 4 h after PRL administration prevented the increase in TH activity.
It was somewhat surprising that PRL receptor expression could not be correlated with the responsiveness of dopaminergic neurons to PRL stimulation. Dopaminergic cells cultured in a serum-free, chemically defined medium expressed PRL receptors, but did not respond to PRL treatment. The confirms previous data from our laboratory (25) and from that of Porter and colleagues (24) that there was no significant increase in TH activity in response to PRL treatment with cells in defined medium. All cultures were started in serumcontaining medium for 18 -24 h, but this brief exposure did not impart PRL responsiveness to the cells if they were sub- sequently cultured in defined medium for 9 days. In contrast, inclusion of FBS in the maintenance medium for the entire 10 days conferred PRL responsive to the dopaminergic neurons. Indeed, Sarkar (26) and Beyer et al. (27) previously reported an increase in TH activity with cells cultured in serum-containing medium. Thus, it appears that a serum factor contributes to the ability of cultured dopaminergic neurons to respond to PRL by a mechanism other than altered PRL receptor expression. However, we cannot rule out the possibility that other cell types were responsive to PRL in the cultures, even with defined medium.
Understanding of the signal transduction pathways for the PRL receptor has increased remarkably during the last few years, and these are currently being intensely investigated in a number of cellular models (21, (41) (42) (43) (44) (45) (46) (47) . It is not clear whether components of the signal transduction pathways are altered in the dopaminergic neurons during conditions of nonresponsiveness vs. responsiveness to PRL, but this hypothesis requires further investigation. PRL-responsive and -nonresponsive states are not unique to the cell culture system. There are in vivo precedents for TIDA neurons to become unresponsive to PRL stimulation during normal physiological changes and in response to hormonal manipulations. TIDA neurons do not respond to PRL treatment during midlactation (12, 13) or in estrogen-treated ovariectomized rats (48). This is somewhat paradoxical because estrogen stimulates PRL receptor mRNA in peripheral tissues (49) and increases PRL binding in the hypothalamus (14) . Moreover, PRL receptor mRNA levels are greatest in the mammary gland during lactation (50). Although a role for decreased PRL receptor expression cannot be entirely dismissed without further investigation, these data do not support the idea that decreased PRL receptor expression contributes to the unresponsive state of TIDA neurons to PRL stimulation in vivo.
In conclusion, the colocalization of PRL receptor and TH supports a direct effect of PRL on dopaminergic neurons, but an indirect effect resulting from PRL's action on another neuronal cell type(s) cannot be ruled out. Identification of the other PRL receptor-containing neurons could contribute to our understanding of PRL's action in hypothalamic cells. The lack of correlation between PRL receptor expression in dopaminergic neurons and degree of responsiveness to PRL stimulation raises significant questions. Investigation of the intracellular events that occur within the dopaminergic neurons in response to PRL stimulation and which of these events are compromised in the nonresponsive state would aid in our understanding of PRL's action.
